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Abstract: Deubiquitinating enzymes (DUBs) have an essential role in several cell biological processes
via removing the various ubiquitin patterns as posttranslational modification forms from the target
proteins. These enzymes also contribute to the normal cytoplasmic ubiquitin pool during the recycling
of this molecule. Autophagy, a summary name of the lysosome dependent self-degradative processes,
is necessary for maintaining normal cellular homeostatic equilibrium. Numerous forms of autophagy
are known depending on how the cellular self-material is delivered into the lysosomal lumen. In this
review we focus on the colorful role of DUBs in autophagic processes and discuss the mechanistic
contribution of these molecules to normal cellular homeostasis via the possible regulation forms of
autophagic mechanisms.
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1. Introduction
The homeostatic equilibrium of the eukaryotic cells is maintained by several cell biological
processes. The cellular self-digestive mechanisms have a main contribution in the fast-cellular
response to the changeable environment. The essential function of these mechanisms is to degrade
several types of cellular components such as a specified part of the cytoplasm, signaling molecules,
proteins and cell organelles. Beside the cellular material breakdown there is another importance
of the self-digestive mechanisms in the cellular life: the eukaryotic cells use these mechanisms to
recycle the essential molecules of the degraded material into the cytoplasm. The unnecessary or
injured components of cells can be degraded by lysosome dependent (autophagy) and independent
(Ubiquitin-Proteasome System—UPS) pathways [1–4]. Importantly, autophagy is responsible for
the breakdown of the significant cytoplasmic material (macromolecules) and cell organelles such as
mitochondria, peroxisomes, ER, part of the nucleus, secretory granules and damaged lysosomes [1,2,5].
In contrast the UPS is only capable of removing and recycling short half-life proteins from the
cytoplasm, which control several signaling pathways [3,4,6]. Unfortunately, various types of
disorders are connected to the reduced function of these self-degradative mechanisms such as
cancer, diabetes, accelerated aging, fatty liver disease (FLD) and infectious, neurodegenerative and
vascular diseases [7–9]. Notably, autophagy and UPS work together and complement each other for the
effective degradation of cellular components which leads to normal homeostatic equilibrium during
various internal or external effects [3,10,11]. Furthermore, ubiquitin, as a frequent posttranslational
modifying molecule, also has a role in proteasome independent mechanisms such as epigenetic
regulation, DNA damage response, mitophagy, cell cycle control, diverse signaling pathways and
intracellular vesicular and protein trafficking mechanisms [12,13].
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In this review we summarize and discuss the main connection points of autophagic degradation
pathways and ubiquitin signaling, especially the role of deubiquitinating enzymes in several
lysosome-dependent self-degradative processes.
2. The Phenomenon of Autophagy
During autophagy the lysosomal compartment, as the terminal place of degradation, has a
central role in digestion and recycling mechanisms. There are four major types of autophagic
processes depending on how cellular materials enter the lysosomal lumen: macroautophagy,
microautophagy, chaperon-mediated autophagy and crinophagy [1,2,5]. Moreover, there are several
“exotic” autophagy-like processes, which were also identified in model systems of yeast and Drosophila
cells (Figure 1) [14–17].
Figure 1. Summary of autophagic and related recycling processes with the connecting deubiquitinases
(DUBs) in the eukaryotic cells. The indicated DUBs occur in metazoan (marked with magenta) and
yeast (marked with blue) cells. The DUBs framed have negative regulation effects in the relevant
autophagic processes.
2.1. Macroautophagy
The best-known lysosome-dependent self-degradative process is macroautophagy, which is the
focus of several biomedical research studies. The main hallmark of this process is the formation of a
phagophore cistern, by which the cytoplasmic components are separated and captured into double
membrane bound autophagosomes. These compartments transport their cargo to the acidic lysosomal
lumen for fast degradation of cytoplasmic molecules and organelles [18]. Autophagosomes were
detected for the first time in 1959 by Novikoff in hydronephrotic renal tissue [19]. Autophagosomes
shape at special sites of the cytoplasm and they are created by the coordinated action of the evolutionary
conserved Atg (Autophagy related) proteins, which form distinct protein complexes. The first set of
atg genes were identified and characterized in yeast (Saccharomyces cerevisiae) by Yoshinori Ohsumi
and his research group [20]. This discovery led to his Nobel Prize in Physiology or Medicine in 2016.
The successful degradation of the autophagosome transported cytoplasmic cargo requires the direct
fusion of these compartments with endosomes and lysosomes. There are main factors, which are
necessary for this membrane fusion step: the tethering complex HOPS (homotypic fusion and vacuole
protein sorting) modulated by normal expression of the Vps8 protein, the small GTPases Rab2, Rab7
(and its partners Mon1/Ccz1 and Plekhm1), Arl8 and the specific SNARE (soluble NSF attachment
protein receptor) proteins including autophagosomal syntaxin 17 (Syx17) and its binding partners
Snap29 and Vamp8 (Vamp7 in Drosophila) [21–31]. As a result of autophagosome-lysosome fusion,
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both the transported cytoplasmic cargo and the inner membrane of the autophagosome are digested,
while the outer autophagosomal membrane blends into the membrane of the resulting secondary
lysosome (autolysosome). The recycling of the monomers released from cargo degradation requires
special efflux transporter proteins (permeases), which are localized in the membrane of lysosomes [32].
This recycling step allows the monomers to be recycled into the cytoplasm where these fuel biosynthetic
and energy production processes.
2.2. Microautophagy and Endosomal Microautophagy
The second form of autophagic processes is microautophagy which is mediated—in plants and
fungi by vacuolar action—during the direct engulfment of the surrounding cytoplasmic cargo [33].
This cytosolic material is trapped in the lysosome/vacuole by a non-selective random process of
membrane invagination to create small intraluminal vesicles, which are then degraded. Depending
on the mechanistic nature of microautophagy, three subtypes of this process are distinguished:
1. microautophagy by lysosomal invagination (this is a classic form), 2. microautophagy through a
lysosomal arm-like protrusion (which encompass the cytoplasmic components) and 3. microautophagy
by endosomal invagination [34]. Latter, namely endosomal microautophagy is a special form of this
process, which typically occurs in metazoans such as Drosophila melanogaster and mammals [5,35].
During endosomal microautophagy the incorporation of the cytoplasmic material is conducted by
late endosomes. Importantly, microautophagy depends on the activity of ESCRT (endosomal sorting
complex required for transport) proteins that also mediate the sorting of internalized receptor ligand
complexes in multivesicular bodies [35,36]. During microautophagy the late endosomal/lysosomal
or vacuolar surface proteins interact with special organelle proteins for their selective degradation.
Moreover, the heat shock cognate 70 kDa protein (HSC70) as a cytosolic chaperone is also necessary
for protein degradation via microautophagy [16,37]. This process may resemble endocytosis a little,
but the topology of microautophagy shows an opposite direction, because the lysosomal lumen is
equivalent with the extracellular space. Several types of cellular organelles such as small secretory
granules, mitochondria, peroxisomes and even part of the nucleus can be degraded by microautophagy.
Even so, the capacity of microautophagic pathway lags behind that of macroautophagy. Importantly,
the cellular survival during starvation or nitrogen deprivation conditions requires the microautophagic
activity, which is also necessary for maintaining cellular homeostasis [1,2,5,35,37,38].
2.3. Chaperone-Mediated Autophagy (CMA)
The special lysosome dependent self-degradative pathway is chaperone-mediated autophagy
(CMA), which operates without the digestion of biological membranes. It involves the selective
degradation of KFERQ-like motif-bearing proteins, which are normally hidden within potential target
proteins [39]. The cytosolic chaperone HSC70 and its cochaperones, such as the carboxyl terminus of
HSC70-interacting protein (CHIP), the heat shock protein 70 and 90 (HSP70–HSP90) organizing protein
(HOP), and HSP40 also known as DNABJ1, are all required for the delivering of the old or damaged
proteins to the lysosomes. Moreover, the exposer of the earlier mentioned KFERQ-like amino acid
sequence on the surface of these proteins is necessary for the recognition and lysosomal degradation of
these abnormal proteins. The target protein internalizes in lysosomes via the channel formed by the
lysosome-associated membrane protein type 2A (LAMP2A). Finally, these captured proteins are rapidly
degraded by lysosomal hydrolases [5,39,40]. CMA as a protein quality control mechanism rapidly
degrades damaged and oxidized proteins which are generated by stress conditions. This process is
also necessary for amino acid recycling through the intensive elimination of low-quality proteins from
the cytoplasm during starved conditions [39,40]. Moreover, CMA also modulates multiple cellular
pathways depending on the nature of the protein substrate that is degraded. Interestingly, CMA, as a
selective remodeling pathway of the proteome, is also required for the regulation of cell cycle, lipid and
carbohydrate metabolism, transcriptional programs and immune responses [40]. It is important to note
that there are no data about deubiquitinating enzymes’ (DUBs) contribution for this type of autophagy.
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2.4. Secretory Granule-Lysosome Fusion (Crinophagy)
Crinophagy is the least known and mysterious type of autophagy during which the unnecessary,
obsolete or damaged secretory granules instead of their exocytosis directly fuse with late endosomes
or lysosomes. This process leads to the fast degradation of unused secretory cargo and the released
monomers able to recycle into the cytoplasm through lysosomal permeases [1,2,41]. The phenomenon
of crinophagy was first identified in 1966 by Smith and Farquhar per the examination of the
lysosomal activity in the anterior pituitary gland of female rats during the lactation process [42].
The molecular background of secretory granule-lysosome fusion was unknown and unclear for a long
time. The first molecule that directly regulates crinophagy was discovered in 2018 by the examination
of developmentally programmed secretory granule degradation in Drosophila late larval salivary
gland cells [43]. Our laboratory identified that crinophagy uses similar molecules to the late step of
macroautophagy (autophagosome-lysosome fusion): the tethering complex HOPS (modulated by
normal Vps8 expression), the small GTP-ases Rab2, Rab7 (and its binding partner Plekhm1), Arl8
and specific SNARE proteins Snap29 Qbc-SNARE and Vamp7 R-SNARE. There is one difference
between the membrane fusion apparat of macroautophagy and crinophagy: the former process uses
syntaxin 17 (Syx17), whereas in contrast, secretory granule-lysosome fusion requires syntaxin 13
(Syx13) [30,31,41,43]. It seems that the type of Qa SNAREs may specify what kind of compartment
is able to fuse with late endosomes or lysosomes. As a result of secretory granule-lysosome fusion,
the transported secretory cargo is fully digested, while the membrane of the secretory granule blends
into the membrane of the resulting secondary lysosome (crinosome) [41,43,44]. The human body
contains several gland tissues, which all use crinophagy to control the secretory vesicle pool, so this
process has huge medical relevance. Crinophagy is upregulated in several disorders (such as acute
pancreatitis and type 2 diabetes), so the molecular background, which leads to zymogen and insulin
granule degradation, should be explored [45–48]. However, the main molecules, which coordinate
the crinophagic membrane fusion mechanisms, have already been identified, but the transcriptional
regulation of this process and the molecular designation of secretory granules for degradation still
remains obscure. Our laboratory currently is working to find answers for these interesting and relevant
questions using the Drosophila salivary gland as a powerful model system [43,49].
2.5. Cytoplasm to Vacuole Targeting (Cvt) Pathway
The cytoplasm to vacuole targeting (Cvt) pathway is a selective type of autophagy in yeast.
This process, considering its mechanistic nature and molecular components, is very similar to
macroautophagy [14]. Proenzymes, (such as the precursor of aminopeptidase 1—preApe1) are
synthetized in the cytosol, aggregate with each other (Ape1), and these particles are specifically captured
by phagophore like structures. Thereafter, these enzymes are packed into double membrane-bound
small autophagosome like vesicles [50]. The core Atg proteins, such as Atg7, Atg8 and Atg9,
which control autophagosome assembly and maturation are also necessary for Cvt vesicle formation.
Several molecules are required for the recognition of Ape1 particles in the cytoplasm, such as the
scaffold protein Atg11 and the receptor molecule Atg19. Finally, the mature Cvt vesicles fuse with the
vacuole in a HOPS-, SNARE- and Rab-dependent manner. Importantly, the aim of this mechanism
is not the degradation of cargo. The supplied bulk Ape1 becomes active by other hydrolases in the
vacuole [14,50,51].
2.6. The Vacuole Membrane Protein Recycling and Degradation (vRed) Pathway
Vacuole membrane protein recycling and degradation (vRed) is a recently identified autophagy-like
pathway for the rapid elimination of the vacuolar efflux lysine transporter Ypq1 from the vacuolar
membrane. It was discovered in 2015 by Li and Emr in lysine starved yeast cells [15]. During this
mechanism the unnecessary lysine transporter Ypq1 after its VAcUL-1-depending polyubiquitination
is selectively sorted off the vacuolar membrane to the small cytoplasmic (vRed) vesicles. The ESCRT
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machinery is recruited to these vesicles, and the polyubiquitinated Ypq1 is sorted into the intraluminal
vesicles of the multivesicular endosomes. Finally, these compartments are delivered into the vacuole
for degradation in a HOPS- and SNARE-dependent manner [15]. Furthermore, similar mechanisms
are responsible for the elimination of the vacuolar Zn2+ influx transporter Cot1 and Zn2+ channel
Zrt3 [16]. Thus, these mechanisms are required for the rapid elimination of vacuolar efflux and influx
transporters as well as ion channels depending on the actual environmental effects [15,16].
2.7. Alkaline Phosphatase (ALP) Pathway
During the alkaline phosphatase (ALP) pathway the resident hydrolases are transported from the
Golgi to the vacuole for activation [14]. ALP is synthesized as an inactive precursor enzyme, which
contains a C-terminal propeptide sequence. The ALP containing vesicles directly fuse with the vacuole
in a HOPS-dependent manner [52,53]. During the activation process the C-terminal propeptide is
cleaved off from the ALP protein by Pep4 vacuolar hydrolase. It is important to note that the ALP
pathway is similar to the lysosome derived vesicle pathway in metazoans [14,52–54].
2.8. Vacuole Import and Degradation (Vid) Pathway
The vacuole import and degradation (Vid) pathway is a special autophagic mechanism, which can
be found in yeast cells after glucose readdition. This phenomenon was discovered by Chiang
and Schekman in 1991 via the examination of glucose starved yeast cells [14,55]. During glucose
deprivation yeast cells produce a high amount of gluconeogenic enzymes, such as Fructose 1-6
BisPhosphatase (FBPase), Malate DeHydrogenase 2 (MDH2), Phosphoenol-pyruvate carboxykinase 1
(Pck1) and Isocitrate lyase 1 (Icl1) in the cytoplasm [56]. After glucose readdition to the media, yeast
cells degrade these enzymes really quickly in two ways: on one hand gluconeogenic proteins can
be polyubiquitinated by the CTLH domain containing E3 ubiquitin ligase complex (Gid—glucose
induced degradation) for the proteasomal breakdown of these proteins [57,58]. On the other hand,
gluconeogenic enzymes can also be captured into small vesicles (Vid vesicles), then these compartments
fuse with the vacuole directly (Vid pathway) [55,59], which leads to the really fast degradation of these
obsolete cytoplasmic enzymes.
3. Short Overview of the Ubiquitination System
3.1. Ubiquitin as a Multiple Importance Posttranslational Modification Molecule
Ubiquitin, a highly conserved 76 amino acid protein, is expressed in all cell types and is
fundamental to various biological functions [60]. Ubiquitin, as a well-known posttranslational
modification of several substrates with covalent conjugation, typically connects via Lys residues,
although sometimes via Cys, Ser and Thr residues. The induction or reversion of ubiquitination (similar
to other posttranslational modifications) is regulated by special enzymes. Usually, there is a single
ubiquitin activator enzyme (E1), but there are many species of ubiquitin conjugating enzymes (E2s)
and multiple families of E3 ubiquitin ligases or E3 multiprotein complexes in a cell (Figure 2) [60–62].
Ubiquitin has several possible molecular sites for various types of posttranslational modifications,
such as acetylation, phosphorylation, sumoylation, neddylation and ubiquitination. Interestingly,
ubiquitin has seven Lys residues (K6, K11, K27, K29, K33, K48 and K63), all of which can be attached
with other ubiquitin molecules to give rise to isopeptide-linked polyubiquitin chains. Moreover,
the eighth chain type is the methionine (Met1)-linked or linear chain, which is also generated on
ubiquitin by the attaching to the N-terminus of a second ubiquitin (Figure 2) [12,63,64]. Importantly,
the type of the polyubiquitin chain conjugated to the substrate can specify the fate of the protein
substrate, by which ubiquitination may influence various forms of biological pathways. Approximately,
there are 1000 E3 enzymes, which have a role in these colorful substrate ubiquitination processes in
mammals [65]. Thus, these types of enzymes play critical roles in the regulation of numerous biological
functions via the ubiquitination of the key substrates. The most well-known and understood function
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of the target substrate ubiquitination is the protein designation for proteasomal degradation with K11-
or K48-linked polyubiquitin chains [60,66]. The biological outcomes of the substrate ubiquitination
depend on the modification type of the key substrate proteins (Figure 2); therefore, they are not all
limited to the proteasomal degradation of substrates [67]. For instance, ubiquitination may have a role
in substrate protein stability, conformation and interactome profile. Interestingly, the polyubiquitin
assembly may also contain branched chains with different types of ubiquitin linkage [12,65].
Figure 2. Overview of the ubiquitinating system (Abbreviations: Ub—ubiquitin, E1—ubiquitin
activating enzyme, E2—ubiquitin conjugating enzyme, E3—ubiquitin ligase, DUB—deubiquitinase
enzyme, Met—methionine, K—lysine).
3.2. The Opposite Effect of Ubiquitination: The Role of Deubiquitinases
Ubiquitination is a reversible reaction. Approximately 100 deubiquitinating enzymes (DUBs)
play a role in this process in mammalian cells (Figure 2) [68]. DUBs are classified into six families:
“ubiquitin C-terminal hydrolases” (UCHs), “ubiquitin-specific proteases” (USPs), “ovarian tumor
proteases” (OTUs), Josephins and JAB1/MPN/MOV34 metalloenzymes, and “motif interacting with
Ub-containing novel DUB family” (MINDY) [69]. There are three possible mechanisms by which
DUBs can remove ubiquitin modifications: 1. endo-cleavage happens between the ubiquitin moieties,
2. exo-cleavage affects to the distal ubiquitin moiety and 3. the base-cleavage removes the whole
ubiquitin chain from the substrate. Thus, the different DUBs, which have distinct specificities for
linkage types of ubiquitination, can control the removal of ubiquitin chains from several types of
protein substrates [68–71].
4. The Activity of Deubiquitinating Enzymes in Autophagic Mechanisms
In the second part of this review we gave a detailed overview about the mechanistic nature
of lysosome-dependent self-degradative processes. Now, we will summarize the role of the most
important DUBs in certain autophagic processes (Figure 1).
4.1. DUBs in Macroautophagy
The ubiquitination system, as well as deubiquitinating enzymes, is strongly involved in many
aspects of macroautophagy, which was summarized in several review articles by Grumati and
Jacomin [72,73]. The ubiquitin-proteasome system (UPS) has a main role in the ubiquitination
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and degradation of autophagy regulator proteins, which may directly affect autophagic flux.
Several autophagy regulators, such as LC3 family members, with ubiquitin tags may also influence
the regulation of autophagy via effecting protein folding and interactomes. For instance, the recently
identified mechanism clearly shows that autophagy is negatively regulated by the ubiquitin activating
protein Ubp6, and its interactor partner Birc6 ubiquitin ligase, via the polyubiquitination and designation
for proteasomal degradation of the key macroautophagic factor LC3 (Atg8) [74]. However, the relevant
DUBs, which have an opposite effect for LC3 stabilization, have not yet been identified. Moreover, the
Lys33-linked ubiquitin chains can interact with the p62 autophagic receptor, and this interaction at the
surface of autophagosomes is necessary for autophagosome formation [75].
The early step of macroautophagic machinery requires double-membrane-bound phagophore
emergence in the cytoplasm and autophagosome formation. The main regulating factor of phagophore
formation is the mammalian target of rapamycin (mTOR) which is negatively regulated by DEPTOR
inhibiting the kinase activity of mTOR. In normal conditions DEPTOR is degraded continuously
by the ubiquitin-proteasome system. During nutrient deprivation DEPTOR is stabilized by Otub1
deubiquitinase, which is the prerequisite of mTOR inactivation and contributes to the assembly of the
Atg1/ULK1 complex (Atg1/ULK1, Atg13, Atg101), which is required for phagophore formation [73].
Importantly, the key member of this complex, Atg1/ULK1, is also positively regulated by Usp20
via the deubiquitination and stabilization of the Atg1/ULK1 protein. Atg6/Beclin1 activity, which
is initialized and stabilized by Usp10 and Usp13 is necessary for expansion of the phagophore
membrane [73]. Moreover, Usp33 also positively regulates Atg6/Beclin1 via the deubiquitination of its
positive regulator protein RALB, by which Usp33 promotes the interaction of these proteins, thereby
stimulating phagophore membrane growth. The negative regulation of Atg6/Beclin1 is materialized by
the activity of Usp14 via the cleaving of K63-linked polyubiquitin chains from Atg6/Beclin1 rather
than K48-linked chains, which designates this protein for proteasomal degradation [73]. Moreover, the
positive transcriptional regulation of Atg6/Beclin1 and its binding partner Atg14L by the nucleolar
localized DUB Usp36 is also necessary for autophagosome formation and Parkin-mediated mitophagy.
Usp36 may have a role in the deubiquitination of the transcriptionally active chromatin marker
histone 2B (H2B), which contributes to the positive transcriptional regulation of Atg6/Beclin1 and
Atg14L [76]. Moreover, the aggregated proteins, intracellular bacteria and damaged mitochondria
tagged with ubiquitin chains can be brought to the autophagosomal membrane via an autophagy
receptor [77]. Interestingly, the selective macroautophagy also requires the contribution of DUBs for
their normal mechanism. For example, the Parkin mediated macromitophagy (selective degradation
of damaged mitochondria by macroautophagy) is negatively regulated by the deubiquitination
activity of Usp30 on the mitochondrial outer membrane proteins [78–80]. Moreover, Usp8 facilitates
macromitophagy by deubiquitination and stabilization of Parkin E3 ubiquitin ligase [73]. In the yeast
model system, the operation of Ubp3 is important for the selective autophagic degradation of 60S
ribosomes (macroribophagy). Interestingly, the deubiquitination of these ribosomal subunits by Ubp3
designates for selective macroautophagic degradation of these macromolecular complexes [81].
Autophagosome-lysosome fusion is a prerequisite of the autolysosome formation and the
cytoplasmic cargo degradation. Kim et al. recently identified that Usp14 is an essential factor
for autophagosome-lysosome fusion via the rescue of the microtubule-associated protein Tau (MAPT)
from proteasomal degradation. Importantly, this protein has a role in the maintenance of microtubular
dynamics and, thereby, in membrane fusion mechanisms, such as autophagosome-lysosome
fusion [82,83]. Moreover, Usp14 may also be necessary to evade UVRAG (UV radiation resistance
associated gene) from proteasomal degradation by its deubiquitination [82]. It is important to note that
the UVRAG containing Vps34 kinase complex is required for lysosome maturation via the delivery of
lysosomal hydrolases and membrane proteins from the Golgi to the lysosomal compartment [54,84].
Autophagic degradation also strongly depends on the activity of the v-ATP-ase proton pump
and lysosomal hydrolases such as cathepsins [54,85,86]. The positive transcriptional regulation of
cathepsin L (CTSL) by the activity of COP9 signalosome subunit 6 (CSN6) deubiquitinase was identified
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in cervical cancer cells [87]. Importantly, yeast orthologs of the above-mentioned DUBs also may
contribute to the Cvt pathway in yeast, but little data is available on this.
4.2. Deubiquitinases in Microautophagy and Endosomal Microautophagy
Lysosomal and endosomal uptake of the neighboring cytosolic material is an important autophagic
process as well. Usp8 (also known as UBPY) has an essential role in the deubiquitination of
endocytosed membrane proteins prior to their lysosomal delivery and degradation, and is also
required for multivesicular endosome (MVE) formation via its interaction with ESCRT proteins, such as
ESCRT-0, the interplay of which leads to the stabilization of ESCRT machinery and multivesicular
body formation [88–91]. Importantly, the ESCRT complex is also necessary for lysosomal/vacuolar
microautophagy [36,38]. Based on the mechanistic similarity of microautophagy and endosomal
microautophagy, it is possible that Usp8 (and his high scored orthologue in yeast Ubp5) also may
have a functional role in lysosomal microautophagic process. Other endosomal deubiquitinase is
the associated molecule with the SH3 domain of STAM (AMSH), which is necessary in the normal
endosomal maturation processes. AMSH is able to cleave K48- and K63-linked polyubiquitin chains
on the target proteins, such as ESCRT-0, which leads to the stabilization and activity alteration of
these targets [92]. Importantly, the stabilized ESCRT proteins are the prerequisites for multivesicular
endosome formation and lysosomal microautophagy [36,89,91]. The loss of function of AMSH and Usp8
causes a similar phenotype: accumulation of endocytic proteins in the endosomal compartments [90,92].
Taken together, the cooperation of AMSH and Usp8 endosomal DUBs is necessary for multivesicular
endosome formation and endocytic cargo degradation.
4.3. The Possible Role of Other DUBs in Autophagy-Like Vesicular Trafficking Mechanisms
Several lysosome-dependent self-degradative processes use vesicular trafficking machinery to
fuse the transported cargo-containing vesicle with the lysosome/vacuole.
Crinophagy is often used by several types of gland cells for the removal of unsecreted secretory
granules from the cytoplasm. During this process the obsolete secretory vesicles directly fuse with
late endosomes/lysosomes for the fast elimination of the secretory cargo [41,42]. Crinophagy is the
least known autophagic process, but the molecules which coordinate the direct fusion of secretory
granules and lysosomes were recently identified. For example, Rab7, a small GTPase occurring often
in lysosome-dependent vesicular trafficking processes, is also necessary for crinophagy [27,43,93].
Our laboratory earlier showed that Rab7 is present on the surface of glue containing secretory granules
before their fusion with late endosomes and lysosomes in Drosophila late-larval salivary glands. It is
possible that Rab7 designates the obsolete secretory granules for degradation as a HOPS recruiting
factor [43]. Interestingly, Sapmaz et al. recently identified that the late endosomal deubiquitinase
Usp32 is required for the positive regulation of Rab7 recycling and recruitment to the late endosomal
membranes. Moreover, the deubiquitination of Rab7 by Usp32 is necessary for transporting late
endosomes to the lysosomal compartment [94]. Based on these results, it is possible that all Rab7 (and
Ypt7 in yeast) dependent autophagic mechanisms, such as the MVE-lysosome fusion, autolysosome
and crinosome formation, Cvt, ALP and the Vid pathway may also require the activity of Usp32, or its
high scored yeast orthologue Ubp12.
Doa4 is the most commonly used DUB in vesicular trafficking processes by yeast cells. For example,
in the vRed pathway, which is responsible for the selective degradation and recycling of the lysine
efflux transporter (Ypq1), the influx Zn2+ transporter (Cot1) and the Zn2+ channel (Zrt3) molecules
from the vacuolar membrane [15,16]. These transporter and channel molecules are ubiquitinylated by
E3 ubiquitin ligases (Rsp5 and Tul1). Importantly, the Doa4 depleted cells showed highly ubiquitinated
Ypq1 molecules on the vRed pathway. In conclusion, Doa4 may have a counter effect in the regulation of
vRed and similar mechanisms, which may contribute to several monomer recycling pathways [15,16].
During the vacuolar import and degradation (Vid) pathway the unnecessary gluconeogenic
enzymes are packed into small vesicles, which then directly fuse with the vacuole in yeast cells after
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glucose readdition [55]. The Vid pathway also requires Ypt7, which raises the possibility that Ubp12,
the potential Ypt7 regulatory DUB in the yeast—based on the Usp32 data [94]—is also necessary for Vid
vesicle-vacuole fusion [59]. Moreover, Wolters et al. recently evinced a possible regulatory connection
between Vid27 (which is required for Vid vesicle clusters formation during the Vid pathway) and
Doa4 molecules. Imaginably, Vid27 may act as a cofactor, which interacts with other DUBs partially
redundant with Doa4 for its activation [95,96].
Importantly, vesicular trafficking mechanisms also require normal microtubule dynamics and
motor proteins. Several articles show that Cylindromatosis (Cyld), a DUB, has an essential role in
the regulation of microtubule dynamics. For instance, Gao et al. identified that, Cyld interacts with
tubulins, and the activity of this DUB is required for microtubule assembly and maintaining its stability.
Consequently, it is possible that Cyld is also necessary for several autophagic processes, which use
vesicular trafficking mechanisms [83,97–100].
Taken together, lysosome dependent self-degradative pathways are richly controlled by several
types of deubiquitinases, thereby, the latter have an essential role in the regulation of these autophagic
processes (Figure 1). These relevant DUBs are summarized in Table 1.
Table 1. Summary of the relevant deubiquitinases and their effects in several autophagic processes.
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Table 1. Cont.
Deubiquitinase Autophagy Type Targets Effects References
Usp14 Macroautophagy Atg6/Beclin1,MAPT, UVRAG
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5. Conclusions and Future Perspectives
Protein ubiquitination is a multi-functional reversible post-translational modification that affects all
cellular processes. Over the past decade there have been considerable advances in the understanding of
the function of DUBs, their mechanism of action and regulation. Recently, there has been an increasing
body of evidence attesting that ubiquitination plays a crucial role in regulating various forms of
autophagy, and DUBs interfere at several steps in these.
Autophagic processes are essential in maintaining normal cellular homeostasis via degrading and
recycling unnecessary or damaged self-material from the cytoplasm. In this review we summarized the
mechanism and molecular background of the known lysosome dependent self-degradative pathways.
Autophagy has a colorful appearance in cells depending on the type of degraded cellular material [1].
Interestingly, ubiquitin, as a posttranslational signaling molecule, has a multiple role in the regulation of
these processes [101]. Importantly, deubiquitinases may have several possible effects in the regulation
of autophagic mechanisms.
1. Stabilization/destabilization of autophagic substrates. Ubiquitination and deubiquitination of
autophagy substrates, as well as components of the autophagic machinery, are critical regulatory
mechanisms of autophagy. The deubiquitination of these factors often causes its stabilization and
contributes to several types of autophagy which take place. For instance, the activity of AMSH and Usp8
is necessary for the rescue of ESCRT proteins from proteasomal degradation [89,91,92]. Moreover, Usp8
also has a role in the stabilization of the macromitophagic key regulator, Parkin [73]. Thereby, Usp8
contributes to the macro- and microautophagic processes, too. It is important to note that Usp14 can
stabilize the microtubule-associated protein Tau (MAPT) and UVRAG, the activity of which is necessary
for all lysosomal fusion and degradation events [73]. On the other hand, the operation of Usp14 may
cause the destabilization of Atg6/Beclin1 by removing K63-linked polyubiquitin chains rather than
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K48-linked chains from this substrate, so this DUB may obstruct the assembly of autophagosomes [82].
Interestingly, the deletion of ubiquitin from the 60S ribosomes by Ubp3 designates these macromolecules
for their selective macroautophagic degradation (macroribophagy) [81]. Nota bene, the removal of
ubiquitin patterns from substrates or autophagy proteins by DUBs is also essential for the regulation of
these pathways.
2. Regulation of protein localization. Deubiquitination also has an effect on the autophagic protein
intracellular localization. For example, Usp32 deubiquitinates the late endosomal marker Rab7,
which is important for the recruitment of this protein to the late endosomes, and is also necessary in
these protein recycling mechanisms [94]. Imaginably, this Usp32 dependent regulation of Rab7 may be
essential in all lysosomal fusion events, such as autolysosome and crinosome formation as well as
MVE-lysosome fusion. Importantly, Ubp12, which is a high scored orthologue of Usp32 in yeast, may
have a role in “exotic” autophagic mechanisms, such as vRed-, Cvt-, ALP- and Vid vesicle-vacuole
fusion events.
3. Transcriptional regulation of the autophagic factors are also regulated by several DUBs. For instance,
Usp36 (localized in the nucleolus) has an essential role in the enhancing of the Atg6/Beclin1 and
Atg14L expression levels. These proteins are required for the formation of autophagosomes,
so the deubiquitinase activity of Usp36 indirectly facilitates autophagosome growth and thereby
macroautophagy, especially macromitophagy [76]. On the other hand, the expression level of the
lysosomal hydrolase Cathepsin-L (CTSL) is positively regulated by CSN6 deubiquitinase in cervical
cancer cells [87]. It seems likely that CSN6 has a main contribution in the normal lysosomal maturation
process, which is a prerequisite for the proper lysosomal degradation of several cytoplasmic and
membrane bound substrates.
4. Facilitation of microtubule assembly and maintaining its dynamics took place by the activity of
Cyld [97,99]. Importantly, the normal microtubule dynamics may also be essential for autophagy-like
vesicular trafficking mechanisms, such as MVE-, autophagosome-, secretory granule-lysosome fusion
and vRed-, Cvt- ALP- and Vid vesicle-vacuole fusion [83].
Deregulation in both autophagy and ubiquitination/deubiquitination processes has been linked to
many pathological processes such as diabetes, neurodegenerative diseases, cancer onset and progression,
accelerated aging mechanisms and different kinds of viral or bacterial infections. Consequently,
autophagic processes, and also relevant DUBs, have high medical relevance [102]. The investigation
of the connection between lysosome-dependent degradative pathways and their ubiquitin-mediated
regulation is necessary for a better understanding of the pathological background of several autophagy
connected disorders. Therefore, it is very important to study further the role of deubiquitinases in
several types of lysosome-dependent self-degradative mechanisms, which may provide the opportunity
to develop new therapies and drugs for more efficient treatment of autophagy related disorders.
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